Modernized tetracycline antibiotic, NUZYRA, added as alternate agent to treat plague
by Press Release from Outbreak News Today on (#5NS62)
By NewsDesk @bactiman63 Boston-based biopharmaceutical company, Paratek Pharmaceuticals announced the novel, once-daily oral and intravenous antibiotic NUZYRA(R) (omadacycline) has recently been added to the Center for Disease Control and Prevention's (CDC) updated report, Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response. NUZYRA was added as an alternative agent for the treatment, [...]
The post Modernized tetracycline antibiotic, NUZYRA, added as alternate agent to treat plague appeared first on Outbreak News Today.